Home › Neuroqore, Inc. › NQ TMS
NQ TMS
Neuroqore, Inc. · Model NQv1-MU-01 · UDI-DI 00860012355402
OBP
Prescription
10
510(k) clearances
340
Adverse events (2 deaths)
6
Recalls
26
Facilities
Description
The NQ TMS system is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medications in the current episode.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-08-24 | Neuronetics, Inc. | Cables are not in conformance with the product specifications required in the production of the HP Coil Assembly. |
| 2020-03-23 | The Magstim Company Limited | It was identified that there is a potential for the Stim Interconnecting high Voltage Cable located at the rear of the Rapid2 and Horizon power supply unit to fail. |
| 2020-03-23 | The Magstim Company Limited | It was identified that there is a potential for the Stim Interconnecting high Voltage Cable located at the rear of the Rapid2 and Horizon power supply unit to fail. |
| 2018-10-25 | The Magstim Company Limited | A stray strand of stainless-steel cable may protrude from the heat shrink sleeving on the Balance Cable of the Ez Arm. |
| 2017-09-28 | The Magstim Company Limited | Users manuals not supplied with 4800-00T US Rapid Therapy System |
| 2009-03-16 | Neuronetics, Inc. | SenStar Treatment Link may have an open circuit that during use with the NeuroStar TMS Therapy system may cause arcing and heat damage to the SenStar and/or treatment coil. Heatin |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.